Anand Divakaran
Affiliations: | University of California, Berkeley, Berkeley, CA, United States |
Area:
Chemical Biology, EpigeneticsGoogle:
"Anand Divakaran"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David E Benson | research assistant | 2010-2013 | Calvin College | |
| Daniel A. Harki | grad student | 2015-2021 | UMN | |
| (Co-advised) | ||||
| William C. Pomerantz | grad student | 2015-2021 | UMN | |
| (Co-advised) | ||||
| Daniel K. Nomura | post-doc | 2021- | UC Berkeley | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hong SH, Divakaran A, Osa A, et al. (2024) Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation. Acs Chemical Biology |
| Divakaran A, Harki DA, Pomerantz WCK. (2023) Recent progress and structural analyses of domain-selective BET inhibitors. Medicinal Research Reviews |
| Divakaran A, Scholtz CR, Zahid H, et al. (2022) Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader. Acs Medicinal Chemistry Letters. 13: 1621-1627 |
| Cui H, Divakaran A, Hoell ZJ, et al. (2022) A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes. Journal of Medicinal Chemistry |
| Cui H, Carlson AS, Schleiff MA, et al. (2021) 4-Methyl-1,2,3-Triazoles as -Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity. Journal of Medicinal Chemistry |
| Kalra P, McGraw L, Kimbrough JR, et al. (2020) Quantifying the Selectivity of Protein-Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins. Acs Chemical Biology |
| Pomerantz WCK, Cui H, Divakaran A, et al. (2020) Selective N-terminal BRD4 bromodomain inhibitors by targeting non-conserved residues and structured water displacement. Angewandte Chemie (International Ed. in English) |
| Divakaran A, Kirberger SE, Pomerantz WCK. (2019) SAR by (Protein-Observed) F NMR. Accounts of Chemical Research |
| Carlson AS, Cui H, Divakaran A, et al. (2019) Systematically Mitigating the p38α Activity of Triazole-based BET Inhibitors. Acs Medicinal Chemistry Letters. 10: 1296-1301 |
| Divakaran A, Talluri SK, Ayoub AM, et al. (2018) Molecular Basis for the N-Terminal Bromodomain and Extra Terminal (BET) Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. Journal of Medicinal Chemistry |